Abstract
Background
In 2015, the Advisory Committee on Immunization Practices recommended Meningococcal
B vaccination for healthy 16- to 23-year-olds based on shared clinical decision-making
between the patient and the provider. There has been some confusion regarding how
to implement this recommendation.
Methods
Through discussions among the authors, a review of relevant literature, and consultation
with vaccine experts, we developed educational materials for providers that included
a patient handout to help initiate and guide conversations leading to shared clinical
decision-making for the Meningococcal B vaccine. Materials were distributed to 88
health care providers who subsequently completed surveys to evaluate their impressions
of the materials and the utility of the materials for clinical practice.
Results
The survey results from the 88 providers revealed that they valued the materials;
93% percent indicated they would share these materials with colleagues, and 95% agreed
or strongly agreed that they would share these materials with patient families. Responses
to an open-ended question indicate that some providers initiated discussions regarding
the Meningococcal B vaccine in ways that truncated conversation rather than encouraging
a shared decision-making process.
Conclusions
Overall, the materials developed and implemented for this project support the initiation
of, and help standardize provider conversations regarding, Meningococcal B vaccination
for healthy adolescents.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Academic PediatricsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020.MMWR Recomm Rep. 2020; 69: 1-41
- Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: a systematic review and meta-analysis.Microb Pathog. 2019; 134103571
- Enhanced Meningococcal Disease Surveillance Reports, 2015.US Department of Health and Human Services, CDC, Atlanta, Ga2017 (Available at:)https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2015.pdfDate accessed: March 9, 2022
- Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015.MMWR Morb Mortal Wkly Rep. 2015; 64: 608-612
- Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015.MMWR. 2015; 64: 1171-1176
Advisory Committee on Immunization Practices. Summary Report, June 26-27, 2019. Available at: https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-2019-06-508.pdf. Accessed July 24, 2021.
- Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices.MMWR Morb Mortal Wkly Rep. 2019; 68: 698-702
- Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >/=65 years: updated recommendations of the Advisory Committee on Immunization Practices.MMWR Morb Mortal Wkly Rep. 2019; 68: 1069-1075
- Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcalvaccine recommendations.Hum Vaccin Immunother. 2020; 16: 933-944
- Knowledge and attitudes regarding category B ACIP recommendations among primary care providers for children.Acad Pediatr. 2018; 18: 763-768
- Adoption of serogroup B meningococcal vaccine recommendations.Pediatrics. 2018; 142https://doi.org/10.1542/peds.2018-0344
- National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2019.MMWR Morb Mortal Wkly Rep. 2020; 69: 1109-1116https://doi.org/10.15585/mmwr.mm6933a1
- Understanding the category B recommendation for serogroup B meningococcal vaccine.Pediatrics. 2017; 139e20163484https://doi.org/10.1542/peds.2016-3484
Available at: https://www.cdc.gov/vaccines/acip/acip-scdm-faqs.html. Accessed August 10, 2021.
- 279. Improving meningococcal B vaccination among US college students.J Adolesc Health. 2020; 66: S141https://doi.org/10.1016/j.jadohealth.2019.11.282
Available at: http://www.icmje.org/recommendations/. Accessed September 30, 2021.
- The architecture of provider-parent vaccine discussions at health supervision visits.Pediatrics. 2013; 132: 1037-1046https://doi.org/10.1542/peds.2013-2037
- Parents not Keeping up With Teen Vaccines.C.S. Mott Children’s Hospital National Poll on Children’s Health, University of Michigan, Michigan2017: 29 (Available at:)http://mottpoll.org/reports-surveys/parents-not-keeping-teen-vaccinesDate accessed: March 9, 2022
- Realizing shared decision-making in practice.JAMA. 2019; https://doi.org/10.1001/jama.2019.9797
- Shared decision making: a model for clinical practice.J Gen Intern Med. 2012; 27: 1361-1367
Agency for Healthcare Research and Quality. The SHARE approach. Essential steps of shared decision-making: expanded reference guide with sample conversation starters. Available at:https://www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/shareddecisionmaking/tools/tool-2/share-tool2.pdf. Accessed March 3, 2020.
Lee GM. Shared Clinical Decision–Making For Immunization Recommendations. 2020. Available at:https://www.gotostage.com/channel/ff5edf4ebb134ec481037f5c774daa3f/recording/62c4059dfe71461fadfd80cb3d5be82a/watch. Accessed February 19, 2020.
- Strength and clarity of vaccine recommendations influence providers’ practice.Pediatrics. 2018; 142e20181633
- Suboptimal uptake of meningococcal vaccines among older adolescents: barriers, solutions, and future research directions.Hum Vaccin Immunother. 2020; 16: 3208-3212
- Parental awareness of meningococcal B vaccines and willingness to vaccinate their teens.Vaccine. 2019; 37: 670-676
- US College Students are at increased risk for Serogroup B meningococcal disease.J Pediatr Infect Dis Society. 2020; 9: 244-247
- Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.BMC Public Health. 2020; 20: 1109
- Implementation experience with meningococcal serogroup B vaccines in the United States.Pediatr Infect Dis J. 2021; 40: 269-275
- Announcements versus conversations to improve HPV vaccination coverage: a randomized trial.Pediatrics. 2017; 139e20161764
- Factors associated with receipt of meningococcal B vaccine among United States adolescents, National Immunization Survey-Teen, 2017-2018.J Adolesc Health. 2021; https://doi.org/10.1016/j.jadohealth.2021.04.029
- Meningococcal B vaccination coverage among older adolescents in the United States.Vaccine. 2021; 39: 2660-2667
- Patient decision aid in vaccination: a systematic review of the literature.Expert Rev Vaccin. 2020; 19: 305-311
Article Info
Publication History
Published online: January 22, 2022
Accepted:
January 11,
2022
Received:
August 19,
2021
Footnotes
Conflict of interest: A.B.M.’s institution received funding via a services agreement with Pfizer, Inc to complete this project. She served as Principal Investigator. Outside of the current research, G.D.Z. has served as a consultant and advisory board member to Merck and as an advisory board member to Moderna. He also has received investigator-initiated research funding from Merck administered through Indiana University. A.K.S. is a Pfizer employee and may hold stock or stock options. B.A.A. has no conflicts of interest to disclose.
Identification
Copyright
© 2019 Published by Elsevier Inc. on behalf of Academic Pediatric Association
